RTS,S疟疾疫苗可带来重大的公共卫生效益。 - Suppr

Suppr

超能文献

RTS,S malaria vaccine could provide major public health benefits.

作者信息

Schuerman Lode

机构信息

GlaxoSmithKline, Wavre 1300, Belgium.

出版信息

Lancet. 2019 Aug 31;394(10200):735-736. doi: 10.1016/S0140-6736(19)31567-3. Epub 2019 Jul 9.

DOI:10.1016/S0140-6736(19)31567-3

PMID:31300170

Abstract

摘要

相似文献

RTS,S malaria vaccine could provide major public health benefits.RTS,S疟疾疫苗可带来重大的公共卫生效益。

Lancet. 2019 Aug 31;394(10200):735-736. doi: 10.1016/S0140-6736(19)31567-3. Epub 2019 Jul 9.

Development of the RTS,S/AS malaria candidate vaccine.RTS,S/AS 疟疾候选疫苗的研制。

Vaccine. 2009 Dec 30;27 Suppl 6:G67-71. doi: 10.1016/j.vaccine.2009.10.013.

Country specific predictions of the cost-effectiveness of malaria vaccine RTS,S/AS01 in endemic Africa.非洲疟疾流行国家中疟疾疫苗RTS,S/AS01成本效益的具体预测。

Vaccine. 2017 Jan 3;35(1):53-60. doi: 10.1016/j.vaccine.2016.11.042. Epub 2016 Nov 24.

Implementation of the malaria candidate vaccine RTS,S/AS01.疟疾候选疫苗RTS,S/AS01的实施

Lancet. 2016 Jan 23;387(10016):318-319. doi: 10.1016/S0140-6736(15)00807-7. Epub 2015 Nov 6.

Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial.RTS,S/AS01E 候选疟疾疫苗与扩大免疫规划疫苗联合接种的安全性和有效性：一项随机、开放标签、2 期临床试验的 19 个月随访。

Lancet Infect Dis. 2011 Oct;11(10):741-9. doi: 10.1016/S1473-3099(11)70100-1. Epub 2011 Jul 22.

[The malaria vaccine candidate RTS,S/AS is in phase III clinical trials].疟疾候选疫苗RTS,S/AS正在进行三期临床试验。

Ann Pharm Fr. 2010 Nov;68(6):370-9. doi: 10.1016/j.pharma.2010.07.002. Epub 2010 Oct 13.

Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial.RTS,S/AS02疟疾疫苗对冈比亚半免疫成年男性恶性疟原虫感染的疗效：一项随机试验。

Lancet. 2001 Dec 8;358(9297):1927-34. doi: 10.1016/S0140-6736(01)06957-4.

Mosquirix (RTS,S): a novel vaccine for the prevention of Plasmodium falciparum malaria.Mosquirix（RTS,S）：一种用于预防恶性疟原虫疟疾的新型疫苗。

Ann Pharmacother. 2012 Mar;46(3):384-93. doi: 10.1345/aph.1AQ634.

Clinical development of RTS,S/AS malaria vaccine: a systematic review of clinical Phase I-III trials.RTS,S/AS疟疾疫苗的临床开发：对I-III期临床试验的系统评价

Future Microbiol. 2015;10(10):1553-78. doi: 10.2217/fmb.15.90. Epub 2015 Oct 6.

Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial.RTS,S/AS02A疟疾疫苗预防莫桑比克儿童恶性疟原虫病的保护期：一项随机对照试验的单盲延长随访

Lancet. 2005 Dec 10;366(9502):2012-8. doi: 10.1016/S0140-6736(05)67669-6.

引用本文的文献

iDC-targeting PfCSP mRNA vaccine confers superior protection against Plasmodium compared to conventional mRNA.与传统mRNA相比，靶向未成熟树突细胞的恶性疟原虫环子孢子蛋白mRNA疫苗对疟原虫具有更强的保护作用。

NPJ Vaccines. 2025 Feb 19;10(1):34. doi: 10.1038/s41541-025-01089-x.

Application of Machine Learning in a Rodent Malaria Model for Rapid, Accurate, and Consistent Parasite Counts.机器学习在快速、准确和一致的寄生虫计数啮齿动物疟疾模型中的应用。

Am J Trop Med Hyg. 2024 Sep 10;111(5):967-976. doi: 10.4269/ajtmh.24-0135. Print 2024 Nov 6.

Immature dendritic cell-targeting mRNA vaccine expressing PfCSP enhances protective immune responses against liver infection.表达恶性疟原虫环子孢子蛋白的靶向未成熟树突状细胞的mRNA疫苗可增强针对肝脏感染的保护性免疫反应。

Res Sq. 2024 Jul 9:rs.3.rs-4656309. doi: 10.21203/rs.3.rs-4656309/v1.

Protein Structure Predictions, Atomic Model Building, and Validation Using a Cryo-EM Density Map from Hepatitis B Virus Spherical Subviral Particle.利用乙型肝炎病毒球形亚病毒颗粒的冷冻电镜密度图进行蛋白质结构预测、原子模型构建及验证

Bio Protoc. 2023 Jul 20;13(14):e4751. doi: 10.21769/BioProtoc.4751.

The Multistage Antimalarial Compound Calxinin Perturbates Ca Homeostasis by Targeting a Unique Ion Channel.多阶段抗疟化合物卡尔西宁通过靶向一种独特的离子通道扰乱钙稳态。

Pharmaceutics. 2022 Jun 28;14(7):1371. doi: 10.3390/pharmaceutics14071371.

Oral Administration of Piperine as Curative and Prophylaxis Reduces Parasitaemia in ANKA-Infected Mice.口服胡椒碱用于治疗和预防可降低ANKA感染小鼠的寄生虫血症。

J Trop Med. 2022 Mar 22;2022:5721449. doi: 10.1155/2022/5721449. eCollection 2022.

Genetic diversity of Plasmodium falciparum AMA-1 antigen from the Northeast Indian state of Tripura and comparison with global sequences: implications for vaccine development.来自印度东北部的特里普拉邦的恶性疟原虫 AMA-1 抗原的遗传多样性与全球序列的比较：对疫苗开发的影响。

Malar J. 2022 Feb 22;21(1):62. doi: 10.1186/s12936-022-04081-1.

Antimalarial Activity of Inhibitors of the Human GTPase Rac1.抗疟药 Rac1 抑制剂的抗疟活性。

Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0149821. doi: 10.1128/AAC.01498-21. Epub 2021 Nov 1.

Engineering a multi epitope vaccine against SARS-CoV-2 by exploiting its non structural and structural proteins.利用 SARS-CoV-2 的非结构蛋白和结构蛋白工程设计多表位疫苗。

J Biomol Struct Dyn. 2022;40(19):9096-9113. doi: 10.1080/07391102.2021.1924265. Epub 2021 May 26.

Immunotherapy and vaccination against infectious diseases.传染病的免疫疗法和疫苗接种。

Wien Klin Wochenschr. 2021 Jul;133(13-14):714-720. doi: 10.1007/s00508-020-01746-2. Epub 2020 Dec 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验